Patents Assigned to NAVEH PHARMA (1996) LTD
  • Publication number: 20180256640
    Abstract: A composition including a hydrate form of magnesium oxide, denoted as MgO.(H2O)n, at a concentration ranging from 1 to 100 weight percent (wt %), where n is any value from 0.1 to 2. The composition may further include MgO at a concentration ranging from 0 to 99 wt %; or Mg(OH)2, at a concentration ranging from 0 to 99 wt %; or Mg(OH)2 at a concentration ranging from 0 to 99 wt %, and MgO, at a concentration ranging from 0 to 99 wt %.
    Type: Application
    Filed: May 8, 2018
    Publication date: September 13, 2018
    Applicant: Naveh Pharma (1996) Ltd.
    Inventor: Nitsan PRIMOR
  • Publication number: 20180064754
    Abstract: A composition including a hydrate form of magnesium oxide, denoted as MgO.(H2O)n, at a concentration ranging from 1 to 100 weight percent (wt %), where n is any value from 0.1 to 2. The composition may further include MgO at a concentration ranging from 0 to 99 wt %; or Mg(OH)2, at a concentration ranging from 0 to 99 wt %; or Mg(OH)2 at a concentration ranging from 0 to 99 wt %, and MgO, at a concentration ranging from 0 to 99 wt %.
    Type: Application
    Filed: November 9, 2017
    Publication date: March 8, 2018
    Applicant: Naveh Pharma (1996) Ltd.
    Inventor: Nitsan PRIMOR
  • Patent number: 9849148
    Abstract: A composition including a hydrate form of magnesium oxide, denoted as MgO.(H2O)n, at a concentration ranging from 1 to 100 weight percent (wt %), where n is any value from 0.1 to 2. The composition may further include MgO at a concentration ranging from 0 to 99 wt %; or Mg(OH)2, at a concentration ranging from 0 to 99 wt %; or Mg(OH)2 at a concentration ranging from 0 to 99 wt %, and MgO, at a concentration ranging from 0 to 99 wt %.
    Type: Grant
    Filed: June 13, 2016
    Date of Patent: December 26, 2017
    Assignee: Naveh Pharma (1996) Ltd.
    Inventor: Nitsan Primor
  • Publication number: 20160287629
    Abstract: A composition including a hydrate form of magnesium oxide, denoted as MgO.(H2O)n, at a concentration ranging from 1 to 100 weight percent (wt %), where n is any value from 0.1 to 2. The composition may further include MgO at a concentration ranging from 0 to 99 wt %; or Mg(OH)2, at a concentration ranging from 0 to 99 wt %; or Mg(OH)2 at a concentration ranging from 0 to 99 wt %, and MgO, at a concentration ranging from 0 to 99 wt %.
    Type: Application
    Filed: June 13, 2016
    Publication date: October 6, 2016
    Applicant: Naveh Pharma (1996) Ltd.
    Inventor: Nitsan PRIMOR
  • Publication number: 20140348952
    Abstract: A composition including a hydrate form of magnesium oxide, denoted as MgO.(H2O)n, at a concentration ranging from 1 to 100 weight percent (wt %), where n is any value from 0.1 to 2. The composition may further include MgO at a concentration ranging from 0 to 99 wt %; or Mg(OH)2, at a concentration ranging from 0 to 99 wt %; or Mg(OH)2 at a concentration ranging from 0 to 99 wt %, and MgO, at a concentration ranging from 0 to 99 wt %.
    Type: Application
    Filed: March 3, 2014
    Publication date: November 27, 2014
    Applicant: NAVEH PHARMA (1996) LTD
    Inventor: NITSAN PRIMOR
  • Patent number: D821567
    Type: Grant
    Filed: February 8, 2017
    Date of Patent: June 26, 2018
    Assignee: NAVEH PHARMA (1996) LTD
    Inventors: Joseph Feldman, Nitzan Primor